Companion Diagnostics - Streamlining drug development and advancing personalized medicine

August 19, 2017, 12:43 am

≫ Next: Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment

$

0

0

---

Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment

August 19, 2017, 12:43 am

≫ Next: Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

≪ Previous: Companion Diagnostics - Streamlining drug development and advancing personalized medicine

$

0

0

Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

August 19, 2017, 12:43 am

≫ Next: Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases

≪ Previous: Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment

$

0

0

Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases

August 19, 2017, 12:43 am

≫ Next: Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

≪ Previous: Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

$

0

0

Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

August 19, 2017, 12:43 am

≫ Next: Pediatric Drug Development - Regulatory challenges and commercial opportunities

≪ Previous: Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases

$

0

0

Pediatric Drug Development - Regulatory challenges and commercial opportunities

August 19, 2017, 12:43 am

≫ Next: Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

≪ Previous: Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

$

0

0

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

August 19, 2017, 12:43 am

≫ Next: Biosimilars - Biosimilars on the cusp of a new era

≪ Previous: Pediatric Drug Development - Regulatory challenges and commercial opportunities

$

0

0

Biosimilars - Biosimilars on the cusp of a new era

August 19, 2017, 12:43 am

≫ Next: Opioids Market Overview to 2023 - Opioids in Western Europe

≪ Previous: Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

$

0

0

---

Opioids Market Overview to 2023 - Opioids in Western Europe

August 19, 2017, 12:43 am

≫ Next: Opioids Market Overview to 2023 - Opioids in Emerging Markets

≪ Previous: Biosimilars - Biosimilars on the cusp of a new era

$

0

0

Opioids Market Overview to 2023 - Opioids in Emerging Markets

August 19, 2017, 12:43 am

≫ Next: Womens Health - Assessing the Need for a Targeted and Specialized Approach

≪ Previous: Opioids Market Overview to 2023 - Opioids in Western Europe

$

0

0

Womens Health - Assessing the Need for a Targeted and Specialized Approach

August 19, 2017, 12:43 am

≫ Next: Mens Health - Changing Male Attitudes to Health to Improve Prognosis and Outcomes

≪ Previous: Opioids Market Overview to 2023 - Opioids in Emerging Markets

$

0

0

Mens Health - Changing Male Attitudes to Health to Improve Prognosis and Outcomes

August 19, 2017, 12:43 am

≫ Next: Biosimilars - Regulatory Framework and Pipeline Analysis

≪ Previous: Womens Health - Assessing the Need for a Targeted and Specialized Approach

$

0

0

Biosimilars - Regulatory Framework and Pipeline Analysis

August 19, 2017, 12:43 am

≫ Next: Life Cycle Management Strategies - Optimizing revenues and defending generic competition

≪ Previous: Mens Health - Changing Male Attitudes to Health to Improve Prognosis and Outcomes

$

0

0

Life Cycle Management Strategies - Optimizing revenues and defending generic competition

August 19, 2017, 12:43 am

≫ Next: Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook

≪ Previous: Biosimilars - Regulatory Framework and Pipeline Analysis

$

0

0

Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook

August 19, 2017, 12:43 am

≫ Next: The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

≪ Previous: Life Cycle Management Strategies - Optimizing revenues and defending generic competition

$

0

0

---

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

August 19, 2017, 12:43 am

≫ Next: Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets

≪ Previous: Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook

$

0

0

Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets

August 19, 2017, 12:43 am

≫ Next: Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs

≪ Previous: The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

$

0

0

Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs

August 19, 2017, 12:43 am

≫ Next: Companion Diagnostics - Streamlining drug development and advancing personalized medicine

≪ Previous: Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets

$

0

0

Companion Diagnostics - Streamlining drug development and advancing personalized medicine

October 21, 2017, 8:07 pm

≫ Next: Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment

≪ Previous: Human Drugs For Veterinary Use - Current Trends and Future Commercial Prospects for Crossover Drugs

$

0

0

Telemedicine - The Future is Now for Moving Telemedicine into Mainstream Treatment

October 21, 2017, 8:07 pm

≫ Next: Immunotherapy Development Strategies - An Evolving Market with Significant Potential but with Challenging Hurdles to Overcome

≪ Previous: Companion Diagnostics - Streamlining drug development and advancing personalized medicine

$

0

0